Home »
Academic Articles & Research Papers
Showing 20 of 21 academic articles
Attachaipanich T, Girotra S, Kennedy KF, McNally BF et al. • Circulation
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1161/CIRCULATIONAHA.126.079735
PMC: PMC13536967
Jing Yang, Pengfei Li, Pengfei Li, Pengfei Li et al. • Frontiers in Immunology
(2022)
ObjectiveExtranodal natural killer/T cell lymphoma (NKTCL) is an aggressive EBV-related lymphoma, originating from NK cells or T cells. Previous study demonstrated that CD56 negative NKTCL should be recognized as a distinct subtype. In this...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2022.829366
Senyefia Bosson-Amedenu, Emmanuel Ayitey, Francis Ayiah-Mensah, Luyton Asare • BMC Cancer
(2025)
Abstract Background Frailty models are extensively utilized in survival analysis to address unobserved heterogeneity among individuals. However, selecting the most robust model for survival prediction, especially in the context of high-dime...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12885-025-14040-z
Wei Liao, PhD, Meredith Ray, PhD, Carrie Fehnel, BBA, Jordan Goss, MA et al. • JTO Clinical and Research Reports
(2024)
Introduction: Low-dose computed tomography screening (LDCT) and lung nodule programs (LNP) promote early lung cancer detection, improve survival; Multidisciplinary Care Programs (MDC) promote guideline-concordant care. The impact of such pr...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jtocrr.2023.100629
Jihye Lee, Teresa Marshall, Harleah Buck, Mulder Pamela et al. • Children
(2025)
Background/Objectives: Growth failure is a common complication in children with congenital heart disease (CHD), yet its underlying mechanisms and consequences remain incompletely understood. This review aims to provide a comprehensive overv...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/children12050616
Yawei Sun, Shuai Wang, Xingwei Zhang, Zhuhao Wu et al. • Biomolecules
(2021)
Background: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a key enzyme that catalyzes the hydroxylation of lysine, plays a crucial role in the progression of several solid tumors. However, its spatial expression profile and pr...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/biom11121842
Xuanzhao Chen, Zeyan Li, Meihua Liang, Ziyang Zhang et al. • World Journal of Surgical Oncology
(2023)
Abstract Background Triple-negative breast cancer (TNBC) is the most heterogenous and aggressive subtype of breast cancer. Chemotherapy remains the standard treatment option for patients with TNBC owing to the unavailability of acceptable t...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12957-023-03078-7
Vishal Sundaram, Isabella Jazrawi BA, Rushani K. Cameron MS, Cody Perskin et al. • Orthopaedic Journal of Sports Medicine
(2026)
Objective: Meniscal allograft transplantation (MAT) is a joint-preserving option for patients with symptomatic meniscal deficiency unresponsive to nonoperative care. By restoring tibiofemoral load transmission, MAT can relieve pain, improve...
DOAJ
Open Access (DOAJ)
DOI: 10.1177/2325967126S00369
Yanshang Wang, Xiaoping Wei • BMJ Open
(2026)
Introduction Electronic patient-reported outcome (ePROs)-based symptom monitoring benefits health-related quality of life (HRQoL) in various cancers. However, despite the high disease and economic burden of hepatocellular carcinoma (HCC) an...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/bmjopen-2026-116199
Liya Ma, Bin Liang, Huixian Hu, Wenli Yang et al. • Frontiers in Oncology
(2022)
The outcomes of myelodysplastic syndrome (MDS) patients with SF3B1 mutation, despite identified as a favorable prognostic biomarker, are variable. To comprehend the heterogeneity in clinical characteristics and outcomes, we reviewed 140 MDS...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fonc.2022.905490
Wei Liu, Yan Xu, Yi Wang, Lugui Qiu et al. • Journal for ImmunoTherapy of Cancer
(2024)
Background Over 50% of patients with relapsed or refractory large B-cell lymphoma (r/r LBCL) receiving CD19-targeted chimeric antigen receptor (CAR19) T-cell therapy fail to achieve durable remission. Early identification of relapse or prog...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/jitc-2023-008450
Marilyne Jarjour, Anique Ducharme • Drugs in Context
(2023)
Heart failure is a growing epidemic with high mortality rates and recurrent hospital admissions that creates a burden on affected individuals, their caregivers and the whole healthcare system. Throughout the years, many randomized trials ha...
DOAJ
Open Access (DOAJ)
DOI: 10.7573/dic.2023-5-6
Luyao Zhang, Jianwen Zhou, Yanyan Sun, Yaodong Zhang et al. • Discover Oncology
(2026)
Abstract Background Primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL) constitutes 30%-40% of primary extranodal lymphomas. While rituximab has significantly improved survival in nodal DLBCL, its impact on the prognosis of P...
DOAJ
Open Access (DOAJ)
DOI: 10.1007/s12672-026-05022-z
Taghi Rezaei, safiyeh mehri nejad • مدیریت بهره وری
(2026)
Business improvement has always been one of the basic issues in the business world. Due to the growing changes in technology, pervasive competition and the changing needs of customers, companies must pay attention to the permanence and impr...
DOAJ
Open Access (DOAJ)
Akhilesh M Wodeyar, Sherin James, Benjamin B. Kasten, Nicolaus D. Knight et al. • Scientific Reports
(2026)
Abstract Achieving negative surgical margins remains a critical determinant of local recurrence and survival in head and neck cancer (HNC) surgery. Current intraoperative margin assessment techniques, including frozen section analysis, suff...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-026-56078-4
Susheel Kumar Nethi, Venugopal Gunda, Nagabhishek Sirpu Natesh, Brianna M. White et al. • iScience
(2025)
Summary: Pancreatic cancer (PC) exhibits profound metabolic adaptations that support tumor progression, survival, and therapy resistance. Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of these processes, promoting metabolic reprog...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.isci.2025.114088
Fangmin Zhong, Fangyi Yao, Zihao Wang, Bo Huang et al. • npj Precision Oncology
(2025)
Abstract Acute myeloid leukemia (AML) remains challenging due to molecular heterogeneity and limited prognostic models integrating tumor microenvironment dynamics. While thrombocytopenia correlates with poor outcomes, the roles of platelet-...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41698-025-01137-8
Claire Tardiveau, Claire Tardiveau, Guillaume Monneret, Guillaume Monneret et al. • Frontiers in Immunology
(2022)
Immune responses affiliated with COVID-19 severity have been characterized and associated with deleterious outcomes. These approaches were mainly based on research tools not usable in routine clinical practice at the bedside. We observed th...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2022.1022750
Caroline W. Grant, Jerry Li, Swan Lin, Dana Nickens et al. • Clinical and Translational Science
(2025)
ABSTRACT Patient outcomes in advanced renal cell carcinoma (RCC) remain poor, with five‐year survival rates ranging from ~10% to 30%. Early projections of therapeutic outcomes could optimize precision medicine and accelerate drug developmen...
DOAJ
Open Access (DOAJ)
DOI: 10.1111/cts.70348
M.Á. Luján, R. Young-Morrison, V. Kashtelyan, G. Loewinger et al. • Cell Reports
(2026)
Summary: Quickly adapting behavior to changing environments is key for survival. Brain dopamine signals reinforce actions that procure rewards and avoid adverse outcomes. However, the molecular mechanisms within the circuits that actuate th...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.celrep.2026.117298